SCHEMBL1019855

SCHEMBL1019855

CCC(CC)NC(=O)CN1CCCNCC1

nearest known ligand 0.67

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CHRM5 P08912 2/20 0.67
CHRM3 P20309 2/20 0.67
SIGMAR1 Q99720 8/20 0.62
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.39
CYP3A4 P08684 1/20 0.39
GAA P10253 1/20 0.39
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 2/20 0.38
KMT2A Q03164 3/20 0.38
CXCR4 P61073 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 2/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL255190 0.80 CHRM5 (1.00) CHRM5CHRM3SIGMAR1NPC1POLB
SCHEMBL11130645 0.79 CHRM5 (0.62) CHRM5CHRM3SIGMAR1ALDH1A1KMT2A
SCHEMBL1023592 0.78 CHRM5 (0.57) CHRM5CHRM3SIGMAR1NPC1POLB
SCHEMBL3399852 0.76 CHRM5 (0.57) CHRM5CHRM3SIGMAR1ALDH1A1KMT2A
SCHEMBL974224 0.75 SIGMAR1 (0.61) CHRM5CHRM3SIGMAR1NPC1GAA
SCHEMBL12226505 0.73 CHRM5 (0.53) CHRM5CHRM3SIGMAR1GAAALDH1A1
SCHEMBL13381313 0.73 CHRM5 (0.58) CHRM5CHRM3SIGMAR1NPC1POLB
SCHEMBL2915702 0.72 CHRM5 (0.53) CHRM5CHRM3SIGMAR1ALDH1A1KMT2A
SCHEMBL983664 0.72 CHRM5 (0.71) CHRM5CHRM3SIGMAR1NPC1POLB
SCHEMBL4711520 0.72 SIGMAR1 (0.65) CHRM5CHRM3SIGMAR1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011000945-A9 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-04-07 WO disclosed
WO-2011000945-A2 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-01-06 WO disclosed